Can the Flu Shot Lead to a Heart Attack?

The flu shot does not cause heart attacks. Pooled data from clinical trials consistently show the opposite: influenza vaccination is associated with a roughly 25 to 30 percent reduction in heart attack risk among those who receive it, with even larger reductions in cardiovascular death.¹ The question persists because vaccinations do trigger a brief, low-grade inflammatory response, and because heart attacks and other cardiac events occasionally happen to coincide with recent vaccination in a population where cardiac events are already common. Untangling that coincidence from causation turns out to be one of the more thoroughly studied questions in cardiology, and the evidence overwhelmingly favors the vaccine as protective.

What the Pooled Trial Data Show

The strongest evidence comes from meta-analyses that combine results across multiple randomized trials, which limits the chance of being misled by a single unusual study. A 2023 meta-analysis covering more than 9,000 patients found that those who received the flu vaccine experienced about 30 percent fewer major cardiovascular events than those given a placebo. The vaccinated group also had a lower risk of heart attack specifically and a meaningful reduction in cardiovascular death.¹ A separate 2022 meta-analysis of randomized trials found that for every 56 high-risk patients vaccinated, one cardiovascular event was prevented within a year.²

A Cochrane review, widely considered the gold standard for synthesizing clinical evidence, found that cardiovascular death was significantly reduced by influenza vaccination in secondary prevention trials, with composite cardiovascular events also trending downward.³ Not every individual study reaches statistical significance on its own for every endpoint. One meta-analysis focused on heart attack alone found a trend toward reduced risk in vaccinated patients that did not quite reach conventional statistical significance.⁴ But the overall direction of the evidence is remarkably consistent: flu vaccination either helps your heart or makes no measurable difference to it. No meta-analysis of trial data has found that it harms it.

Why the Concern Feels Plausible

The flu vaccine works by provoking your immune system into producing antibodies. That provocation involves a real, measurable inflammatory response, and inflammation is a known contributor to heart attacks. So the concern is not unreasonable on its face.

Studies have documented a modest spike in C-reactive protein (CRP), a common marker of inflammation, after flu vaccination. In one study, CRP rose by about 30 percent above baseline, an increase that was statistically real but clinically small.⁵ Other inflammatory signals like interferon-gamma and IP-10 rise within hours after vaccination, peak somewhere around 16 to 24 hours, and return to normal within about two days.⁶ In men who already had carotid artery disease, the acute-phase inflammatory response was somewhat stronger than in healthy men, though the difference was only statistically significant for one marker, serum amyloid A.⁷

There is also a small, temporary dip in blood-vessel function after vaccination. One study found that flow-mediated dilation of the brachial artery, a measure of how well blood vessels relax, decreased at two days post-vaccination and remained somewhat lower at two weeks.⁸ In isolation, this could sound alarming. But the effect is subtle and self-limited, and it has not translated into actual heart attacks in the trial data. The body handles mild inflammatory provocations routinely. Exercise produces a larger inflammatory spike than a flu shot, and nobody calls a jog a cardiac risk factor.

What Flu Itself Does to the Heart

This is where the real story lives. While the vaccine produces a brief flutter of inflammation, actual influenza infection unleashes a vastly larger one, and the cardiac consequences are dramatic.

A landmark study published in the New England Journal of Medicine found that the rate of heart attacks during the first seven days after a confirmed influenza infection was about six times higher than during a comparable period without infection. After day seven, the increased risk disappeared. Influenza B was especially dangerous, with a tenfold increase in heart attack admissions, while influenza A showed roughly a fivefold increase.⁹ A separate study using UK data found a similar pattern, with heart attack risk peaking at more than four times the baseline during the first three days after respiratory infection, rising even higher in people over 80.¹⁰

The biology behind this is well understood. When the flu hits hard, the body releases a flood of inflammatory cytokines that can destabilize fatty plaques already sitting in coronary arteries. Those plaques may have been silently building up for years and never caused symptoms, but the intense systemic inflammation from a full-blown infection can crack their caps open, triggering a blood clot. At the same time, the stress hormones released during a bad illness cause blood vessels to constrict, platelets to become stickier, and the heart to work harder.¹¹ Influenza viruses also seem to have a particular affinity for vascular tissue, with experimental studies finding viral particles lodged directly in arterial plaques, intensifying local inflammation even without detectable virus in the bloodstream.¹¹

This is the critical comparison the question misses. The vaccine triggers a whisper of inflammation. The infection triggers a roar. By preventing the infection, the vaccine removes the far more dangerous inflammatory event and produces a net cardiovascular benefit.

Vaccination After a Heart Attack or With Existing Heart Disease

You might expect that people who just had a heart attack would be the last group you would want to vaccinate, but the evidence suggests they are the group that benefits most. A trial enrolling patients admitted with acute coronary syndrome found that those vaccinated in the hospital had significantly fewer combined cardiovascular events, including death, recurrent heart attack, heart failure, and stroke, compared with unvaccinated patients. The event rate was roughly half in the vaccinated group.¹²

The FLUCAD trial, which enrolled patients with stable coronary artery disease who were already receiving optimal medical therapy, found that the 12-month rate of coronary ischemic events was significantly lower in the vaccinated group compared with controls.¹³ A broader review incorporating the largest randomized trials, including the IAMI trial, found a pooled reduction in cardiovascular death of about half at 12 months among vaccinated cardiac patients compared with controls.¹⁴ These are not subtle effects. Cardiologists now consider influenza vaccination a legitimate secondary prevention strategy on par with some medications.

Coincidence, Background Rates, and Misattribution

Hundreds of millions of flu shots are administered each year, overwhelmingly to older adults or people with chronic conditions. These are the same people most likely to experience heart attacks regardless of vaccination. When a cardiac event happens a day or two after a flu shot, it is natural to suspect a connection. But the math shows that many such coincidences are expected even if the vaccine has zero effect on the heart.

Background rates of sudden cardiac death in the general population range from roughly 20 to 66 per 100,000 person-years, depending on age and sex.¹⁵ During a mass vaccination campaign, some of those events will occur within hours or days of a shot purely by chance. Passive reporting systems like VAERS capture these temporal associations without determining causation. In VAERS data on the high-dose flu vaccine used mainly in people 65 and older, the most common cause of death among the small number of reported fatalities was circulatory disease, which is also the leading cause of death in that age group period.¹⁶ This does not mean the vaccine caused those deaths. It means that the population getting flu shots is the same population that dies of heart disease at high rates.

Transient Effects on Heart Rhythm and Autonomic Tone

A handful of small studies have looked at whether the mild post-vaccination inflammatory response affects heart rhythm regulation. One study found that heart rate variability, a measure of how well the nervous system fine-tunes your heart rate, dipped slightly in the 48 hours after an adjuvanted flu vaccine.¹⁷ Another found a similar change, but only in the subgroup of volunteers who developed symptoms like arm soreness or mild fever. In the overall group of 71 volunteers, there was no significant reduction in autonomic tone.¹⁸

These findings are physiologically interesting but clinically unimportant for the vast majority of people. The changes are small, transient, and well within what the body handles routinely during mild illness, exercise, or even emotional stress. No clinical study has linked these brief autonomic shifts to actual cardiac events after vaccination. Researchers have treated them as evidence that the inflammatory pathway is worth studying, not as evidence of danger.

High-Dose and Adjuvanted Formulations

People 65 and older are typically offered enhanced versions of the flu vaccine, either high-dose formulations containing more antigen or adjuvanted formulations that include an immune-boosting ingredient. A natural question is whether pushing the immune response harder also pushes cardiac risk higher.

In a large trial comparing high-dose trivalent vaccine with standard-dose quadrivalent vaccine in patients with high-risk cardiovascular disease, there was no significant difference in death or cardiopulmonary hospitalization between the two groups.¹⁹ The high-dose vaccine did not appear to cause more cardiac harm than the standard version, even in a population already prone to events. A large safety database analysis of the MF59 adjuvant, used in some enhanced flu vaccines, found that adjuvanted recipients actually had lower rates of cardiovascular adverse events and death compared with non-adjuvanted recipients. Local reactions like arm soreness were higher with the adjuvanted vaccine, as expected, but serious events were not.²⁰

Myocarditis and Pericarditis After the Flu Shot

The COVID-19 pandemic brought myocarditis, or inflammation of the heart muscle, into public awareness as a rare side effect of certain mRNA vaccines. This naturally led people to wonder whether other vaccines carry a similar risk. For the flu shot, the answer appears to be no.

A large population-based study using a self-controlled design, which compares each person’s risk during a post-vaccination window against their own baseline, found no increase in myocarditis admissions during the six weeks after influenza vaccination. The incidence rate ratios during days one through seven, one through 14, and one through 42 were all below 1.0, meaning myocarditis was actually slightly less common after vaccination than at baseline, though the difference was not statistically significant.²¹ A recent secondary analysis of a large randomized trial comparing high-dose with standard-dose flu vaccine in older adults found that myocarditis or pericarditis events were actually significantly less common in the high-dose group.²² The flu vaccine’s mechanism is different from the mRNA platform, and the cardiac inflammation concern has not materialized in the data.

Sex Differences in Side Effects

Women consistently report more side effects from the flu shot than men, both at the injection site and systemically. A meta-analysis of randomized trials found that women had about a 25 to 40 percent higher rate of local reactions like arm pain and redness, and about a 25 to 27 percent higher rate of systemic reactions like headache and muscle aches, compared with men.²³ This pattern held for both younger and older adults.

These differences are thought to reflect stronger immune activation in women, which is well documented across many vaccines and infections. The relevant point for cardiac concerns is that stronger immune activation still does not translate into cardiac events. The inflammatory response is larger in women on average, but the cardiovascular protection from flu vaccination is not diminished. The increased side effects are almost entirely local reactions and mild systemic symptoms like fatigue and headache, not serious cardiovascular complications.

Why VAERS Reports Do Not Mean What People Think

Much of the online concern about flu shots and heart attacks traces back to VAERS data. VAERS is a passive reporting system: anyone, including patients, family members, and healthcare providers, can submit a report linking any health event to a recent vaccination. The system is designed to detect possible safety signals, not to confirm that a vaccine caused a particular problem. Reports are not verified, and no causal determination is made at the point of submission.

The VAERS database for influenza vaccines receives thousands of reports per season.²⁴ When people see cardiac-related events listed among those reports, they sometimes interpret this as evidence that the vaccine caused those events. But the same reasoning would lead you to conclude that the vaccine causes car accidents, broken hips, and cancer diagnoses, all of which also appear in VAERS simply because they happen to occur in the days after vaccination. The controlled studies described above, where vaccinated and unvaccinated groups are compared under conditions that account for these coincidences, are the ones that actually tell you whether the vaccine contributed to an outcome.

Who Should Be Especially Proactive About Getting Vaccinated

Given that flu infection itself is a potent trigger for heart attacks, the people who benefit most from vaccination are the same ones who might worry most about getting the shot. If you have coronary artery disease, a history of heart attack or stroke, heart failure, or diabetes with cardiovascular complications, you are at elevated risk of a cardiac event during a bad bout of flu. Vaccination cuts that risk substantially. Cardiology guidelines in the United States, Europe, and elsewhere now specifically recommend annual flu vaccination as part of standard cardiac care, placing it alongside medications like statins and blood pressure drugs.

The timing question also comes up: is it safe to vaccinate someone who just had a heart attack and is still in the hospital? The trial evidence says yes. Patients vaccinated during hospitalization for acute coronary syndrome had fewer cardiovascular events over the following year than those who were not vaccinated, and no excess of adverse events was reported in the vaccinated group.¹² The practical challenge is that flu season may not coincide with a hospitalization, but when it does, there is no reason to delay vaccination out of cardiac concern.